Case Reports and Reviews: Open Access

Background: Intragastric balloon (IGB) therapy is a minimally invasive endoscopic intervention for weight reduction in patients with obesity. Although generally safe, rare but clinically significant complications such as acute pancreatitis have been reported. Case Presentation: A 19-year-old male presented with acute epigastric pain, nausea, and vomiting three weeks after intragastric balloon insertion. Laboratory investigations demonstrated markedly elevated serum lipase (>3× upper limit of normal) and leukocytosis. Imaging revealed peripancreatic fat stranding consistent with early acute pancreatitis. The intragastric balloon was endoscopically deflated and removed, followed by supportive management, resulting in complete clinical recovery. Conclusion: Acute pancreatitis is an uncommon but important complication of intragastric balloon therapy. Early recognition and prompt management are essential to achieve favorable outcomes.

Albendazole is a broad-spectrum anthelmintic drug generally regarded as safe. Rarely, it may cause acute toxic hepatitis. We report a case of severe hepatotoxicity following albendazole use in a pediatric patient. Other causes of acute hepatitis were excluded, and the Roussel Uclaf Causality Assessment Method (RUCAM) score was 8, indicating a highly probable drug-induced liver injury.

Lung cancer is the most prevalent cancer in the developed world and the most common cause of cancer-related deaths. Metastasis to the gastrointestinal tract is relatively rare from any primary cancer, and particularly from lung cancer. The most common site of metastases of lung cancer is to the adrenals, liver, bone, and brain. Although metastasis to the gastrointestinal tract remains rare, it is under-diagnosed, and is likely to increase in frequency as patients with primary lung cancer live longer with their disease and therefore suffer more sequelae of advanced disease.